DPP6
A-type potassium channel modulatory protein DPP6
Also known as: DPL1, DPP6_HUMAN, DPPX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42658
- Gene
- DPP6
- Ensembl
- ENSG00000130226
- Chromosome
- 7
- Canonical length
- 865 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a single-pass type II membrane protein that is a member of the peptidase S9B family of serine proteases. This protein has no detectable protease activity, most likely due to the absence of the conserved serine residue normally present in the catalytic domain of serine proteases. However, it does bind specific voltage-gated potassium channels and alters their expression and biophysical properties. Variations in this gene may be associated with susceptibility to amyotrophic lateral sclerosis and with idiopathic ventricular fibrillation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
865 residues, UniProt reviewed canonical sequence.
>P42658|DPP6
1 MASLYQRFTG KINTSRSFPA PPEASHLLGG QGPEEDGGAG AKPLGPRAQA AAPRERGGGG
61 GGAGGRPRFQ YQARSDGDEE DELVGSNPPQ RNWKGIAIAL LVILVICSLI VTSVILLTPA
121 EDNSLSQKKK VTVEDLFSED FKIHDPEAKW ISDTEFIYRE QKGTVRLWNV ETNTSTVLIE
181 GKKIESLRAI RYEISPDREY ALFSYNVEPI YQHSYTGYYV LSKIPHGDPQ SLDPPEVSNA
241 KLQYAGWGPK GQQLIFIFEN NIYYCAHVGK QAIRVVSTGK EGVIYNGLSD WLYEEEILKT
301 HIAHWWSPDG TRLAYAAIND SRVPIMELPT YTGSIYPTVK PYHYPKAGSE NPSISLHVIG
361 LNGPTHDLEM MPPDDPRMRE YYITMVKWAT STKVAVTWLN RAQNVSILTL CDATTGVCTK
421 KHEDESEAWL HRQNEEPVFS KDGRKFFFIR AIPQGGRGKF YHITVSSSQP NSSNDNIQSI
481 TSGDWDVTKI LAYDEKGNKI YFLSTEDLPR RRQLYSANTV GNFNRQCLSC DLVENCTYFS
541 ASFSHSMDFF LLKCEGPGVP MVTVHNTTDK KKMFDLETNE HVKKAINDRQ MPKVEYRDIE
601 IDDYNLPMQI LKPATFTDTT HYPLLLVVDG TPGSQSVAEK FEVSWETVMV SSHGAVVVKC
661 DGRGSGFQGT KLLHEVRRRL GLLEEKDQME AVRTMLKEQY IDRTRVAVFG KDYGGYLSTY
721 ILPAKGENQG QTFTCGSALS PITDFKLYAS AFSERYLGLH GLDNRAYEMT KVAHRVSALE
781 EQQFLIIHPT ADEKIHFQHT AELITQLIRG KANYSLQIYP DESHYFTSSS LKQHLYRSII
841 NFFVECFRIQ DKLLTVTAKE DEEEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DPP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 56 nTPM
- cerebral cortex: 55 nTPM
- endometrium: 51 nTPM
- basal ganglia: 40 nTPM
- hippocampal formation: 38 nTPM
- hypothalamus: 32 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 3,310 nCPM
- podocytes: 3,211 nCPM
- choroid plexus epithelial cells: 3,135 nCPM
- bergmann glia: 2,538 nCPM
- retinal ganglion cells: 2,244 nCPM
- ependymal cells: 1,743 nCPM
Immune cell
- basophil: 0.6 nTPM
- neutrophil: 0.3 nTPM
- NK-cell: 0.2 nTPM
- non-classical monocyte: 0.2 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- pons: 183 nTPM
- hippocampal formation: 136 nTPM
- cerebellum: 130 nTPM
- medulla oblongata: 119 nTPM
- thalamus: 117 nTPM
- cerebral cortex: 116 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DPP6.
Disease | AllUniProt
Conditions DPP6 is implicated in, by any mechanism.
- Familial paroxysmal ventricular fibrillation 2 (VF2) MIM:612956
- Intellectual developmental disorder, autosomal dominant 33 (MRD33) MIM:616311
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 304 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, autosomal dominant 33
- Ventricular fibrillation, paroxysmal familial, 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 2.24
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein localization to plasma membrane
- proteolysis
- regulation of potassium ion transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DPP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DPP6 as an antibody target. Whether an autoantibody or antibody against DPP6 could matter depends on whether native DPP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DPP6 is annotated at the cell surface, where native DPP6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DPP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...